Search

… ProQR Therapeutics Added to NASDAQ Biotechnology Index … & CAMBRIDGE, Mass., Dec. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … and share volume requirements among other criteria. About ProQR ProQR Therapeutics is dedicated to changing lives …

… Lilly and ProQR to Expand RNA Editing Collaboration New agreement … assets directed toward high conviction targets utilizing ProQR’s Axiomer technology INDIANAPOLIS; LEIDEN, Netherlands; …

… ProQR Announces Proposed Public Offering of Ordinary Shares … LEIDEN, the Netherlands, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … public offering.  All of the shares are being offered by ProQR.  In addition, in the public offering, ProQR expects to …

… ProQR Appoints Theresa Heggie as Chief Commercial Officer … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the … brings a wealth of commercial and leadership skills to ProQR, having built commercial organizations and successfully …

… ProQR Announces Upcoming Presentation at RNA Editing Summit … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … said Gerard Platenburg, Chief Scientific Officer of ProQR. “Our presentation at the RNA Editing Summit will …

… ProQR to Present at Upcoming SVB Leerink Conference LEIDEN, … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Events ”. Archived webcasts will be …

… ProQR to Present at Cowen Health Care Conference LEIDEN, … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …

… ProQR Announces Presentations at the OTS Annual Meeting … on QR-110 clinical data in LCA10 David Rodman, MD, EVP of R&D of ProQR, will give a presentation on the recent clinical data …

… ProQR Announces First Quarter 2024 Operating and Financial … & CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) --  ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company … expression of the protein. A strong correlation (R 2 = 0.51) is reported between editing levels of NTCP and …